Follow-up of Adult Phenylketonuria (PKU) Patients

NCT01096758 | Completed

• 1 other identifier: A-PKU2010
• Study Type: observational
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

Adult patients with phenylketonuria (PKU) at the age around 40 years belong to the first patients generation with early treatment of the disease. PKU is caused by an inborn error of the amino acid metabolism and the so far best suitable therapy is an early and strict diet, which is low in phenylalanine. Besides an early and continuously treatment in childhood, the nutritional and medical support during adolescence and adulthood have been suggested to influence the long-term physical health of adult PKU patients. As many adult PKU patients tend to neglect the necessarily strict diet, they do not get a balanced diet. For PKU patients some nutrients, which may be rare in an unbalanced diet, might help to improve health status, physical and neurological performance and quality of life. Information about the longitudinal development of the patients status and the influence of the type of their medical care is not available. In this 5 year follow-up the investigators aim to study the quality of life and the medical, nutritional and psychological status of adult PKU patients, in whom corresponding information has already been collected previously.

Conditions

Nutritional Deficiencies; Phenylketonuria

Keywords

PKU; phenylketonuria; adult; patient; development; nutritional deficiencies; neurological outcome; psychological and neurological development; comparison with healthy adults; longitudinal development; quality of life

Study Arms (2)

PKU patients

healthy controls

Eligibility Criteria

• Age: 25 Years - 70 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult PKU patients who are or have been attending the Departements of Metabolic Diseases of the Klinikum der Universität München will be recruited for this study, if they had been participating already in the last study trial comparing adult PKU patients with healthy controls. It will be attempted to include the same control persons as in the last study trial.

You may qualify if:

• assured clinical diagnose of PKU or proof of mutation in the phenylalanine hydroxylase gene (for PKU patients only)
• both groups need to hand in a signed consent to participate in the study
• controls: have to be omnivores and should not be on drugs, which influence the lipid metabolism, during the last 3 months
• attendance of the last study trial

Sponsors & Collaborators

• Ludwig-Maximilians - University of Munich: lead

Study Sites (1)

Dr. von Hauner Childrens Hospital

München, D-80337, Germany

Location

Biospecimen

Retention: SAMPLES WITH DNA

blood cheek cells

MeSH Terms

Conditions

Malnutrition; Phenylketonurias

Condition Hierarchy (Ancestors)

Nutrition Disorders; Nutritional and Metabolic Diseases; Brain Diseases, Metabolic, Inborn; Brain Diseases, Metabolic; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Amino Acid Metabolism, Inborn Errors; Metabolism, Inborn Errors; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Metabolic Diseases

Study Officials

• Berthold Koletzko, Prof.

  Ludwig-Maximilians - University of Munich

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Prof.

Study Record Dates

• First Submitted: March 30, 2010
• First Posted: March 31, 2010
• Study Start: March 1, 2010
• Primary Completion: September 1, 2012
• Study Completion: September 1, 2013
• Last Updated: September 10, 2013

Record last verified: 2013-09

Locations

DE (1)